TP53 and hepatocellular carcinoma: As all the aforementioned adopted cells are human NSCLC cells, we also used the human hepatoma cell line Hep3B, with a p53 deletion, to test the existence of the p53-miR-138-AGO2-miR-130b-GADD45A pathway.